Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Merck & Company Inc. (new)

Symbol: MRK     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
2.71%
Current Price
$81.27
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-11 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
10,816,000,000
10,816,000,000
3,052,000,000
7,764,000,000
4,356,000,000
3,408,000,000
2,915,000,000
-
-
n.a.
-
-
-
-
-
-
-
 
1,931,000,000

Financials 2018

Update: 2019-06-11 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
10,998,000,000
10,998,000,000
3,289,000,000
7,709,000,000
4,857,000,000
2,852,000,000
1,827,000,000
25,875,000,000
82,637,000,000
55,755,000,000
26,701,000,000
7,967,000,000
5,308,000,000
8,864,000,000
25,114,000,000
204,000,000
3,592,000,000
 
2,214,000,000

Q 3

2018-09-30
10,794,000,000
10,794,000,000
3,619,000,000
7,175,000,000
4,511,000,000
2,664,000,000
1,950,000,000
26,836,000,000
85,130,000,000
52,474,000,000
32,422,000,000
7,828,000,000
3,656,000,000
10,285,000,000
23,592,000,000
2,548,000,000
2,793,000,000
 
2,068,000,000

Q 2

2018-06-30
10,465,000,000
10,465,000,000
3,417,000,000
7,048,000,000
4,782,000,000
2,266,000,000
1,707,000,000
24,064,000,000
85,040,000,000
52,274,000,000
32,529,000,000
5,312,000,000
3,379,000,000
7,594,000,000
23,338,000,000
1,088,000,000
3,382,000,000
 
2,274,000,000

Q 1

2018-03-31
10,037,000,000
10,037,000,000
3,184,000,000
6,853,000,000
5,704,000,000
1,149,000,000
736,000,000
24,085,000,000
86,041,000,000
52,140,000,000
33,668,000,000
4,486,000,000
2,055,000,000
7,346,000,000
23,556,000,000
-1,764,000,000
1,155,000,000
 
3,196,000,000

Financials 2017

Update: 2019-06-11 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
10,433,000,000
10,433,000,000
3,303,000,000
7,130,000,000
4,963,000,000
2,167,000,000
-1,046,000,000
24,766,000,000
87,872,000,000
53,303,000,000
34,336,000,000
6,092,000,000
3,057,000,000
8,498,000,000
24,410,000,000
-1,828,000,000
4,015,000,000
 
2,184,000,000